Danaher Co. (NYSE:DHR) Position Increased by Valley National Advisers Inc.

Valley National Advisers Inc. boosted its stake in Danaher Co. (NYSE:DHR) by 29.9% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 313 shares of the conglomerate’s stock after purchasing an additional 72 shares during the period. Valley National Advisers Inc.’s holdings in Danaher were worth $71,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently added to or reduced their stakes in the stock. Fort Pitt Capital Group LLC increased its holdings in shares of Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate’s stock worth $66,194,000 after acquiring an additional 7,421 shares during the period. Good Life Advisors LLC bought a new position in Danaher in the 3rd quarter worth about $217,000. ORG Partners LLC increased its stake in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock valued at $636,000 after purchasing an additional 2,559 shares during the period. Harvest Portfolios Group Inc. raised its holdings in shares of Danaher by 1.2% during the third quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate’s stock valued at $56,233,000 after buying an additional 2,465 shares during the last quarter. Finally, Stifel Financial Corp boosted its position in shares of Danaher by 1.3% during the third quarter. Stifel Financial Corp now owns 847,348 shares of the conglomerate’s stock worth $235,583,000 after buying an additional 11,216 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 0.2 %

Shares of DHR opened at $222.56 on Monday. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $221.34 and a 1-year high of $281.70. The stock has a market capitalization of $160.75 billion, a P/E ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83. The business’s 50-day moving average price is $235.40 and its 200 day moving average price is $253.08.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same quarter last year, the company earned $2.09 EPS. Analysts expect that Danaher Co. will post 8.15 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a $0.27 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.49%. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Analyst Ratings Changes

DHR has been the topic of several analyst reports. JPMorgan Chase & Co. lowered their target price on Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. KeyCorp raised their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. TD Cowen upped their price objective on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Robert W. Baird lowered their target price on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Finally, Stephens reaffirmed an “overweight” rating and issued a $315.00 price target on shares of Danaher in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $278.00.

Insider Activity

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.